Clinical Trials Directory

Trials / Terminated

TerminatedNCT01126255

Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus

Efficacy of a Topic Therapy With Progesterone Compared to the Conventional Therapy With Clobetasol Propionate in Patients With Vulvar Lichen Sclerosus. A Double Blind, Randomized Phase II Pilot Study.

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a randomized trial comparing progesterone with conventional clobetasol propionate in patients with vulvar lichen sclerosus.

Detailed description

Background A total of 62 female patients with first diagnosis of lichen sclerosus will be treated daily with either topical progesterone 8% or clobetasol propionate 0.05% for 12 weeks. Response to the treatment will be evaluated by macroscopic description of the dermatologic phenotype by using a specific lichen sclerosus score and photography-documentation. The symptoms and quality of life of the patients will be evaluated by standardized questionnaires. Additionally, tissue samples will be taken before and again after 12 weeks of treatment to evaluate the response status. Objective The purpose of this study is to compare progesterone with conventional clobetasol propionate in a superiority trial. Methods Prospective, randomized, controlled, superiority phase II pilot trial. Patients will be randomized 1:1 to either progesterone or clobetasol propionate, with patients, physicians, assessors and analysts being blinded.

Conditions

Interventions

TypeNameDescription
DRUGClobetasol propionate 0.05%Topical application, once daily about 2 g, during 12 weeks
DRUGProgesterone 8%Topical application, once daily about 2 g, during 12 weeks

Timeline

Start date
2011-03-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2010-05-19
Last updated
2022-04-01

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01126255. Inclusion in this directory is not an endorsement.